ZUG, Switzerland--(BUSINESS WIRE)-- Galderma (SWX:GALD) announces positive first results from a trial designed to explore the benefits of Restylane ® Lyft™ or Contour™ in combination with Sculptra ® ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback